Hoffmann-La Roche
Empagliflozin(Hoffmann-La Roche)은 Metastatic Breast Cancer 표적 ADC로, Metastatic Breast Cancer 영역에서 개발·상용화 중입니다. 작용기전: , SGLT2i are associated with osmotic diuresis and natriuresis, restored tubuloglomerular feedback, reduced blood pressure, and maintenance of renal function. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 61건의 관련 임상이 등록되어 있습니다. PK: t½ 12.4 h. 차별점: novel treatment strategies remains an unmet clinical need.
Metastatic Breast Cancer
Metastatic Breast Cancer
Recruiting
novel treatment strategies remains an unmet clinical need
, SGLT2i are associated with osmotic diuresis and natriuresis, restored tubuloglomerular feedback, reduced blood pressure, and maintenance of renal function
apoptosis, immune response, proteolysis, and neuromodulation
biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 dia
downregulation of key virulence-associated genes (fimH and luxS)
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.
Hoffmann-La Roche
Empagliflozin(Hoffmann-La Roche)은 Metastatic Breast Cancer 표적 ADC로, Metastatic Breast Cancer 영역에서 개발·상용화 중입니다. 작용기전: , SGLT2i are associated with osmotic diuresis and natriuresis, restored tubuloglomerular feedback, reduced blood pressure, and maintenance of renal function. Phase 2에서 효능·안전성 신호를 검증 중입니다. ClinicalTrials.gov 기준 61건의 관련 임상이 등록되어 있습니다. PK: t½ 12.4 h. 차별점: novel treatment strategies remains an unmet clinical need.
Metastatic Breast Cancer
Metastatic Breast Cancer
Recruiting
novel treatment strategies remains an unmet clinical need
, SGLT2i are associated with osmotic diuresis and natriuresis, restored tubuloglomerular feedback, reduced blood pressure, and maintenance of renal function
apoptosis, immune response, proteolysis, and neuromodulation
biomarker trajectories with semaglutide, empagliflozin, and sitagliptin in people with obesity and type 2 dia
downregulation of key virulence-associated genes (fimH and luxS)
임상시험이 많습니다. 임상시험 탭에서 Phase/Status 필터·검색을 사용하세요.
수집된 임상 필드(phase, status, endpoint 등) 기반 자동 요약입니다.